PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.\', \'Department of Dermatology, University of New South Wales, Sydney, New South Wales, Australia.\', \'Department of Dermatology, Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/dth.13956
?:hasPublicationType
?:journal
  • Dermatologic therapy
is ?:pmid of
?:pmid
?:pmid
  • 32621628
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.625
?:rankingScore_hIndex
  • 57
?:title
  • Treatment concerns for bullous pemphigoid in the COVID-19 pandemic era.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all